Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
BridgeBio, Pfizer
BridgeBio Gets US Approval for Heart Drug to Compete with Pfizer
BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way for the biotech company to go head-to-head with Pfizer Inc. in an increasingly competitive market.
BridgeBio Wins FDA Approval for ATTR-CM Drug, Launching Competition With Pfizer
BridgeBio secured approval for Attruby Friday, along with the all-important mortality benefit that could give the drug a significant boost in the market against Pfizer’s tafamidis and potentially Alnylam’s Amvuttra.
US FDA approves BridgeBio's drug for rare heart condition
The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said on Friday, making it the first new treatment in a market dominated by Pfizer's blockbuster Vyndaqel.
BridgeBio announces FDA approved Attruby for ATTR-CM patients
Pharma announced that the U.S. Food and Drug Administration approved Attruby, an orally-administered near-complete stabilizer
4d
on MSN
Pfizer names oncology head Chris Boshoff as R&D chief
Pfizer has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, ...
4d
How Pfizer is trying to make U.S. healthcare easier to navigate
The pharma leader is betting that streamlined services may be a shot in the arm for Americans seeking care with its ...
STAT
4d
Doubling down on its strategy, Pfizer names its head of oncology as new research chief
Pfizer, despite pressure from investors to look outside, elevates its cancer chief Chris Boshoff to lead overall R&D.
3d
Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS?
Is Pfizer stock a sell after shares skidded on the news Trump selected Kennedy to take over HHS? Is PFE stock now a sell?
2d
Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination
Pfizer shares are trading lower by 10% in November. President-elect Donald Trump last week announced his intention to nominate Robert F. Kennedy Jr. to lead the HHS.
FierceBiotech
4d
Pfizer plucks internal candidate to replace R&D head Dolsten, triggering series of leadership shakeups
Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own ...
4d
on MSN
Pfizer Names New R&D Chief
Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief ...
13d
Pfizer: The Tide Finally Turning
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
FierceBiotech
2d
Chutes & Ladders—Pfizer replaces retiring CSO with cancer chief
Pfizer has found a successor for retiring Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the ...
4d
Meta, Pfizer on DOL List of Upcoming Contractor Anti-Bias Audits
Meta Platforms Inc, Pfizer Inc and American Airlines are among the companies the Labor Department’s contractor watchdog has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Food and Drug Administration
China
Chris Boshoff
Hympavzi
BridgeBio
Feedback